Bright Peak Therapeutics
PrivateLast Round
Series C
Jun 11, 2024
Total Funding Raised
$232M
Company Overview
Bright Peak Therapeutics is a biotechnology company that develops multifunctional precision immunotherapies for the treatment of cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bright Peak Therapeutics Comparables
Compare Bright Peak Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synthekine | 87% | |
| Asher Biotherapeutics | 84% | |
| Anaveon | 83% | |
Bright Peak Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 11, 2024 | ||||
| Series B | Jun 10, 2021 | ||||
| Series A | Jul 28, 2020 |
Bright Peak Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series C, Series B |
| Northleaf Capital Partners | Series C |
| KB Investment | Series C |
| KB Investment | Series C |
| Fidelity Management & Research Company | Series B, Series C |
| Versant Ventures | Series B, Series C, Series A |
| Alexandria Venture Investments | Series B, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2025
John Schmid appointed to the Board of Directors.
- Jan 6, 2025
Will present at the 43rd Annual J.P. Morgan Healthcare Conference.
Bright Peak Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bright Peak Therapeutics's valuation, stock price, and market status.